Zhejiang Longsheng Group Co., Ltd. Overview
Zhejiang Longsheng is the world's largest producer and service provider of textile chemicals. It has 330,000 tonnes per year of operating dye capacity (430,000 t/y approved), 80,000 t/y of textile auxiliaries and 119,500 t/y of dye intermediates. The group combines a Chinese commodity-scale disperse and reactive dye base with DyStar, the former Bayer/Hoechst/BASF dye business that became wholly owned in January 2026. That gives Longsheng a global brand, a technical-service network and specialty know-how that domestic peers lack. Its main competitive advantage is backward integration into scarce, hazardous intermediates. These include reduction product (3-amino-4-methoxyacetanilide), m-phenylenediamine, resorcinol and H-acid, which make up 60–80% of dye production cost and face tight regulatory limits on new capacity. A second, non-core business holds a large Shanghai real-estate portfolio (Huaxing New Town, Hongkou). That property business inflated revenue volatility in 2022–24 and still ties up a large inventory balance. Longsheng is therefore an integrated specialty-chemicals cyclical with a property tail and a very high dividend payout.
The company's own description
In its periodic reports, Longsheng describes two core businesses:
-
Textile chemicals, led by dyes and auxiliaries.
-
Intermediates, led by m-phenylenediamine (间苯二胺) and resorcinol (间苯二酚).
Real estate is reported separately as an "other/real estate" activity (China Securities Journal summary of the Q1 2026 report, 1 May 2026). The FY2025 annual report and the 2026 interim report describe a "vertical extension" strategy. Under it, the company moves from a single dye business into the wider specialty-chemicals field. It concentrates on core intermediates (resorcinol, p-phenylenediamine, m-aminophenol) and related products such as reduction product.
Independent characterisation
Longsheng is best understood as three economic engines with very different capital intensity, cyclicality and cash profiles.
(a) Integrated dye manufacturing (≈55% of FY2025 revenue). The group produces disperse dyes for polyester, reactive dyes for cotton and cellulosics, and a smaller range of acid, sulphur, vat and other dyes. These are sold mainly as powders and liquids to textile dye houses. The domestic business (Longsheng-branded, Zhejiang-based) is commodity-like and moves with Chinese dye prices. DyStar adds premium branded ranges (Dianix, Levafix, Remazol, Sera auxiliaries, Cadira sustainability systems). It also brings colour-management services (Colour Solutions International / Econfidence) and brand-owner relationships with global apparel retailers.
(b) Intermediates (≈22% of FY2025 revenue). The group makes benzene- and naphthalene-chain intermediates for its own use and for sale. These are m-phenylenediamine (65 kt/y), reduction product (20 kt/y, the world's largest supplier), H-acid (20 kt/y), resorcinol and others. Resorcinol and m-phenylenediamine also go to tyre-rubber adhesion, aramid fibre, UV absorbers and agrochemical markets. Intermediates were the main profit driver in H1 2026, with a 39.56% gross margin. They give the group pricing power when regulators shut smaller, hazardous capacity.
(c) Real estate and other (≈6% real estate plus ≈7% auxiliaries/other in FY2025). The main asset is the Huaxing New Town (华兴新城) redevelopment in Hongkou, Shanghai. It contains for-sale residential units (the "湾上 Wanshang" high-rise, due for handover at end-2026) and held-for-rent apartments and offices, which carry an investment-property balance of CNY 12.7 billion at end-2025. Real-estate revenue is lumpy and is recognised on handover. It fell 67% in FY2025 to CNY 814M.
Revenue model
| Revenue model component | Share of FY2025 revenue | Notes |
|---|---|---|
| Product sales – dyes | ~55% (7,278) | Volume × ASP; ASP CNY 30,057/t in FY2025 |
| Product sales – intermediates | ~22% (2,864) | Includes inter-segment volumes sold externally |
| Product sales – auxiliaries | ~7% (939) | DyStar and domestic auxiliaries |
| Real estate sales and rental | ~6% (814) | Recognised on handover; rental recurring |
| Other (inorganic chemicals, etc.) | ~10% (balance) | Includes sulphuric acid, by-products and trading |
| Subscription / licensing | Not material | No separate disclosure |
Revenue is almost entirely product sales. Services such as colour-management and technical support, and rental income, are small and not separately disclosed. Pricing is spot or short-contract in the domestic market and based on price lists and contracts at DyStar.
Shares are derived from segment figures against total revenue of CNY 13,313M (FY2025 Annual Report, via Great Wall Securities and Guosen).
Value-chain position and customers
Longsheng sits in the middle of the chain, from petrochemical aromatics to the textile dye house. It is integrated upstream, from benzene/naphthalene through intermediates to dyes. Customers include:
Chinese printing and dyeing mills: These are concentrated in Zhejiang (Shaoxing/Keqiao), Jiangsu, Fujian and Guangdong.
International dye houses: in Bangladesh, Vietnam, India, Turkey, Pakistan, Indonesia and Latin America, served mainly through DyStar.
-
Global apparel and footwear brands, which specify DyStar products and sustainability systems.
-
Industrial buyers of intermediates, including tyre/rubber, aramid, agrochemical and pharmaceutical producers.
Property buyers and tenants: in Shanghai.
End-markets are apparel, home textiles, technical textiles, tyres, high-performance fibres and Shanghai residential and commercial property.
Strategy
Stated strategy (FY2025 Annual Report and 2026 Interim Report themes)
-
Global textile-chemicals leadership. Integrate Longsheng and DyStar in technology, brand, channels, capacity and innovation to remain "the world's largest textile chemicals producer and service provider".
-
Vertical integration ("intermediate–dye" eco-integrated system). Keep core intermediates largely self-supplied to build a cost barrier and environmental competitiveness, and keep leading globally in intermediates.
-
Extension into specialty chemicals. Move beyond dyes into high-value intermediates (resorcinol, p-phenylenediamine, m-aminophenol and reduction-product series) with non-textile end-markets.
-
Orderly realisation of real estate. Deliver the Huaxing New Town Wanshang residential handover (end-2026) and maintain rental occupancy for stable cash flow.
-
Shareholder returns. Payouts close to or above 100% of earnings (Guosen calculates 101.9% in FY2023, 109.4% in FY2024 and 103.3% in FY2025). Quarterly dividends started in 2026.
Strategic initiatives in the last 24 months
| Date | Initiative | Detail / target |
|---|---|---|
| Jun–Dec 2024 | Controlling shareholder share purchases | CNY 200–400M on-market plus about CNY 450–550M block purchases from ESOPs |
| May 2025 – Jan 2026 | Full ownership of DyStar | About USD 702M paid. Ends the SICC litigation and removes forced-sale risk. |
| 2025–26 | Upstreaming of DyStar profits | Parent-company retained earnings rose CNY 5.68 billion in H1 2026 to CNY 6.13 billion (Shenwan). This supports dividend capacity, since PRC rules base dividends on parent-level distributable profit. |
| Apr 2026 | Quarterly and interim dividend framework | The AGM authorised the board to set 2026 interim dividends. CNY 0.35/share was paid for Q1 2026. |
| Apr–Jul 2026 | CNY 13 billion DFI registration | SCP/CP/MTN/perpetual notes over 2 years. Gives funding flexibility for dividends, refinancing and possible capex. |
| 2,026 | Employee ownership | The 2021 ESOP term was extended. The 2023 ESOP holds 3.00%. |
| Ongoing | Environmental and safety compliance | Integrated treatment of wastewater, waste gas and solid waste. This is a moat as hazardous intermediates face tighter rules. |
Medium-term targets
Management does not publish formal medium-term revenue or margin targets.
Products & Services
Longsheng does not publish product-level revenue or pricing. The catalogue below combines disclosed capacity data (FY2025 Annual Report and 2026 Interim Report, via Guosen) with DyStar's public brand architecture. List prices are not disclosed. Industry spot prices are given where relevant.
Specialty Chemicals — Dyes
| Product line | Description / chemistry | Capacity & position | Target customers | Flagship brands / grades | Pricing reference |
|---|---|---|---|---|---|
| Disperse dyes | Azo and anthraquinone dyes for polyester, acetate and nylon. Applied by high-temperature exhaust or thermosol. | 140 kt/y, China's largest. Raw-material self-sufficiency close to 100%. | Polyester fabric dyers in China, South and Southeast Asia, Turkey | Longsheng domestic ranges. DyStar Dianix® (incl. Dianix XF/AD), Dianix Black ECT-type navy/black | Disperse Black ECT 300%: CNY 17/kg (Jan 2026) → 34/kg (mid-Mar) → 23/kg (Jun) → 28/kg (25 Aug 2026), versus a 2025 average of CNY 16.59/kg (Baiinfo via Guosen) |
| Reactive dyes | Vinyl-sulphone and monochlorotriazine dyes for cotton, viscose and linen | 70 kt/y, China #3. H-acid capacity 20 kt/y supports it. | Cotton knit and woven mills, home textiles | DyStar Levafix®, Remazol®, Realan® (wool). Longsheng reactive black WNN-type | Reactive Black WNN 150%: CNY 22/kg (Jan 2026) → 36/kg (Aug 2026), +40.9% (Guosen) |
| Acid dyes | For wool, silk and nylon | — | Nylon hosiery, swimwear, carpets, wool | DyStar Telon®, Isolan® | — |
| Vat, sulphur and indigo dyes | For denim and workwear | Not separately disclosed. DyStar is a leading pre-reduced indigo supplier. | Denim mills | DyStar Indigo Vat 40% Solution, Indanthren®, Diresul® | — |
| Direct and cationic dyes | For cellulosics and acrylics | — | Acrylic knitwear, paper | DyStar Astrazon®, Sirius® | — |
| Liquid and digital-print dyes | Ink-jet and liquid dye formulations | — | Digital textile printers | DyStar Jettex® | — |
| Total dyes | — | 330 kt/y operating, 430 kt/y approved | — | — | Disperse dye price index CNY 25/kg and reactive dye CNY 31/kg at end-Jun 2026, +47% and +41% YTD |
Specialty Chemicals — Auxiliaries
| Product line | Description | Capacity | Brands |
|---|---|---|---|
| Pre-treatment auxiliaries | Scouring, wetting, bleaching stabilisers | Part of 80 kt/y | DyStar Sera® range (Sera Wet, Sera Quest) |
| Dyeing auxiliaries | Levelling agents, dispersants, fixing agents | Part of 80 kt/y | Sera Gal, Sera Fix |
| Finishing auxiliaries | Softeners, repellents, functional finishes | Part of 80 kt/y | Sera Fast, Evo-branded systems |
| Sustainable process systems | Low-water, low-energy dyeing systems | — | Cadira® (Reactive, Polyester, Denim, Wool) |
FY2025 auxiliaries revenue was CNY 939M at a 28.99% gross margin, on 61.4 kt sold. In H1 2026, revenue was CNY 459M on 30.4 kt.
Specialty Chemicals — Intermediates
| Intermediate | Use | Capacity (t/y) | Market position / notes |
|---|---|---|---|
| Reduction product (还原物, 3-amino-4-methoxyacetanilide) | Key coupling component for disperse dyes | 20,000 | World's largest supplier. Only three stable Chinese producers: Ningxia Zhongsheng 20 kt, Longsheng 20 kt, Runtu 8 kt; total about 48 kt. Price rose from CNY 25,000/t at end-2025 to about CNY 120,000/t by late July 2026, roughly +380% (Shengyishe via Guosen). |
| m-Phenylenediamine (间苯二胺) | Disperse dye intermediate, aramid (meta-aramid), resins | 65,000 | Global leader (company claim). Sold captively and to merchants. |
| Resorcinol (间苯二酚) | Tyre-cord adhesive resins, UV absorbers, flame retardants, pharma | n/d (included in 119.5 kt total) | One of few global producers outside Sumitomo/INDSPEC. Named strategic focus. |
| H-acid (H酸) | Key reactive-dye intermediate | 20,000 | Effective domestic H-acid capacity is under 60 kt/y, with a >10% supply gap (Runtu disclosure via Guosen). H-acid price was CNY 80,000/t on 25 Aug 2026, double the CNY 40,000/t of early 2026. |
| p-Phenylenediamine (对苯二胺) | Aramid (para-aramid), rubber antioxidants, hair dye | — | Named strategic product (FY2025 Annual Report) |
| m-Aminophenol (间氨基苯酚) | Dyes, pharma, thermal paper colourants | — | Named strategic product |
| Total intermediates | — | 119,500 | — |
Real estate
| Project | Location | Type | Status (H1 2026) |
|---|---|---|---|
| Huaxing New Town "Wanshang" (华兴新城·湾上) | Hongkou District, Shanghai (North Bund area) | High-rise residential for sale | Interior fit-out complete. Pre-viewing preparations under way. Handover targeted for end-2026, which will drive revenue recognition (2026 Interim Report via Great Wall). |
| Huaxing New Town held-for-rent apartments | Same | Rental apartments | Stable occupancy and recurring cash flow |
| Huaxing New Town commercial / office | Same | Office and commercial for rent | Stable occupancy |
Investment property on the balance sheet was CNY 10,370M at end-2024 and CNY 12,710M at end-2025 (Guosen balance sheet).
Services
DyStar provides technical application service, colour communication and digital colour management (including Colour Solutions International), eco-compliance testing and consulting. Its Econfidence® programme covers RSL/MRSL compliance for brands. Service revenue is not separately disclosed.
Financial Narrative
Sources: StockAnalysis (aggregated from statutory filings) for income statement, cash flow and balance-sheet items FY2021–FY2025. Guosen (27 Aug 2026) for FY2024–FY2025 items restated from annual reports. Company filings for headline revenue and net profit FY2025. "Revenue" means total operating revenue as reported (营业总收入).
Income statement
Notes:
-
Diluted EPS equals basic (no dilutive instruments outstanding).
-
FY2024 and FY2025 EPS match reported figures (Guosen). FY2021–23 EPS is derived and may differ slightly from reported weighted-average EPS because of treasury shares held for ESOPs.
-
FY2024 recurring net income is derived from FY2025 recurring net income of CNY 1,606M and the reported –12.59% change.
-
Guosen's "dividend per share" is the cash paid for dividends and interest divided by shares, so it overstates pure declared DPS. The declared FY2022 dividend was CNY 0.25/share (FY2022 Annual Report). The declared FY2025 final dividend was CNY 0.10/share (SSE 2026-023).
-
Effective tax rate: 16.25% in FY2024 and 9.97% in FY2025 (Guosen).
Margin profile
Revenue CAGR FY2021–FY2025: –5.5% per year (derived: (13,313 ÷ 16,660)^(1/4) – 1). Net income CAGR: –14.2% per year.
Income-statement commentary. Three overlapping cycles drive the five-year arc. First, the dye price cycle peaked in 2021, fell to a trough in 2023 and recovered from Q1 2026. Second, real-estate handovers were heavy in 2022 and partly in 2024, then fell away in 2025. Third, raw-material and energy deflation in 2024–25 widened dye spreads even as dye prices fell.
FY2022 shows record revenue but falling profit. Property handovers lifted the top line at lower margins than the 2021 dye peak. FY2023 was the trough: revenue –28% and net profit –49%. FY2024 net profit rebounded 32%. That rebound included roughly CNY 504M of gains on asset disposals (cash-flow reconciliation, StockAnalysis), which flatters the recurring trend. FY2025 had lower revenue but the highest gross margin in four years. Net profit was supported by about CNY 505M of investment gains and a 10% effective tax rate. Recurring profit fell 12.6%.
The inflection came in H1 2026. Recurring net profit rose 27.5% and Q2 2026 recurring profit rose 50% YoY. This happened despite an FX loss of about CNY 216M in Q2 (Shenwan). Finance expense moved from income of CNY 55M in H1 2025 to an expense of CNY 404M in H1 2026, which hid the operating recovery in headline profit.
Balance sheet
Notes:
-
Goodwill is not separately disclosed in the sources accessed. DyStar-related goodwill is believed to be small relative to equity.
-
Minority interests fell from CNY 2,972M to CNY 208M at end-2025 because the DyStar minority stake was bought out. The excess of consideration (about USD 702M) over the book value of the 37.57% stake was charged to equity, which is why parent equity fell CNY 1.6 billion despite profits (company announcement, 16 Dec 2025).
-
Current contract liabilities rose to CNY 12.8 billion, reflecting pre-sale receipts for the Wanshang residential project. These will convert to revenue on handover, expected around end-2026.
At end-Q1 2026, cash and equivalents were CNY 21,918M and net debt was CNY 3,853M (StockAnalysis).
Cash flow
Capex for FY2021–24 is not disclosed in the sources accessed. Guosen shows zero for FY2024, which likely reflects a classification artefact. Longsheng has not run an open-market cancellation buyback programme recently. Its historical buybacks were used to fund ESOPs. In June 2026 the company said it would announce any buyback plan if one is adopted (SSE e-interaction, 4 Jun 2026).
In H1 2026, OCF was CNY 1,799M, down 56.8% YoY because pre-sale receipts were high in H1 2025 (Guosen). In Q1 2026, OCF was CNY 403M (–84% YoY), investing cash flow –CNY 1,788M and financing cash flow +CNY 2,433M (China Securities Journal, 1 May 2026).
Ratios
Interest coverage is not reliably derivable. Net finance expense was negative (net interest income) in FY2024–25: finance income of CNY 415M in FY2024 and CNY 191M in FY2025 (Guosen). The cash conversion cycle is not meaningful because property inventory dominates: inventory turnover of 0.33x implies more than 1,000 days. The Q1 2026 weighted ROE was 1.63% and ROIC 1.11% (China Securities Journal).
Ratio commentary. Returns are structurally low (ROE about 6%) despite healthy chemical margins. The main reason is the size of the balance sheet. About CNY 27 billion of inventory, mostly property under development, plus CNY 12.7 billion of investment property, earn little in most years. Net debt fell from CNY 13.5 billion (FY2022) to about CNY 2–4 billion (FY2024–Q1 2026) as property pre-sale cash came in. The DyStar buy-out (about USD 702M, roughly CNY 5 billion) and the CNY 13 billion DFI registration point to some re-leveraging. Consensus models (Guosen) expect short-term borrowings to rise to more than CNY 20 billion by 2027 if 100% payouts continue.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Income Statement and Margin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue (CNY Mn) | 16,660 | 21,226 | 15,303 | 15,884 | 13,313 |
Revenue YoY growth (%) | 6.76 | 27.41 | -27.90 | 3.79 | -16.18 |
Cost of revenue (CNY Mn) | 11,028 | 14,914 | 11,499 | 11,683 | 9,393 |
Gross profit (CNY Mn) | 5,632 | 6,311 | 3,804 | 4,200 | 3,920 |
SG&A (CNY Mn) | 1,560 | 1,551 | 1,337 | 1,447 | 1,379 |
R&D expense (CNY Mn) | 652.5 | 709.4 | 580.5 | 600.7 | 582.2 |
Operating income, derived = GP − opex (CNY Mn) | 3,286 | 3,675 | 1,874 | 2,034 | 1,863 |
D&A (CNY Mn) | 933.8 | 965.4 | 923.3 | 905.9 | 883.3 |
EBITDA, derived = operating income + D&A (CNY Mn) | 4,220 | 4,640 | 2,797 | 2,940 | 2,746 |
Pre-tax income (CNY Mn) | — | — | — | 2,812 | 2,353 |
Income tax (CNY Mn) | — | — | — | 457 | 235 |
Minority interest (CNY Mn) | — | — | — | 325 | 289 |
Net income attributable to parent (CNY Mn) | 3,374 | 3,003 | 1,534 | 2,030 | 1,829 |
Net income YoY growth (%) | -19.21 | -10.99 | -48.92 | 32.36 | -9.91 |
Recurring (扣非) net income (CNY Mn) | — | — | — | 1,837 | 1,606 |
EPS basic, derived = NI ÷ 3,253M (CNY) | 1.04 | 0.92 | 0.47 | 0.62 | 0.56 |
Dividend per share, cash distributed per Guosen (CNY) | — | — | — | 0.68 | 0.58 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansMargin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Gross margin (%) | 33.81 | 29.73 | 24.86 | 26.44 | 29.44 |
Operating margin, derived (%) | 19.72 | 17.31 | 12.25 | 12.81 | 13.99 |
EBITDA margin, derived (%) | 25.33 | 21.86 | 18.28 | 18.51 | 20.63 |
Net margin (%) | 20.25 | 14.15 | 10.02 | 12.78 | 13.74 |
R&D % of revenue | 3.92 | 3.34 | 3.79 | 3.78 | 4.37 |
Balance Sheet and Per-Share Data
| Metric (CNY Mn, year-end) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Cash & equivalents | 6,878 | 6,875 | 10,893 | 18,056 | 19,515 |
Trading securities | 1,294 | 1,382 | 1,454 | 490 | 623 |
Accounts receivable | 5,132 | 4,995 | 4,159 | 3,537 | 3,853 |
Inventory (incl. property under development) | 28,239 | 28,649 | 29,321 | 28,833 | 27,446 |
Total current assets | 44,006 | 43,288 | 46,982 | 52,313 | 53,429 |
Investment property | — | — | — | 10,370 | 12,710 |
Fixed assets | — | — | — | 6,503 | 6,235 |
Intangibles & other | — | — | — | 595 | 576 |
Long-term equity investments | — | — | — | 2,232 | 2,202 |
Total assets | — | — | — | 72,012 | 75,150 |
Short-term borrowings & trading liabilities | — | — | — | 10,853 | 13,131 |
Long-term borrowings & bonds payable | — | — | — | 3,378 | 1,429 |
Contract liabilities / unearned revenue, current | 5,288 | 1,183 | 2,313 | 7,392 | 12,833 |
Total liabilities | — | — | — | 34,760 | 42,278 |
Minority interests | — | — | — | 2,972 | 208 |
Equity attributable to parent | — | — | — | 34,280 | 32,664 |
Net debt per StockAnalysis (CNY Mn) | 10,360 | 13,530 | 11,335 | 2,160 | 2,656 |
Working capital, derived = current assets − current liabilities (CNY Mn) | — | — | — | 21,765 | 13,311 |
Book value per share (CNY) | — | — | — | 10.54 | 10.04 |
Cash Flow
| Metric (CNY Mn) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Operating cash flow | 4,681 | 956 | 2,751 | 9,265 | 5,837 |
Change in inventory | -4,012 | 788 | -460 | 554 | -629 |
Change in payables & advances | 5,204 | -4,283 | -100 | 5,609 | 5,261 |
Capex | — | — | — | — | 511 |
Free cash flow, derived = OCF − capex | — | — | — | — | 5,326 |
Investing cash flow | — | — | — | 902 | -3,213 |
Financing cash flow | — | — | — | -4,466 | -4,836 |
Net debt issued (repaid) | 8 | 3,132 | 1,943 | -3,009 | 2,074 |
Dividends & interest paid | — | — | — | 2,221 | 1,889 |
Net change in cash | 368 | -35 | 1,276 | 1,683 | -2,339 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
ROE (%) | — | — | — | 5.92 | 5.60 |
ROIC (%) | — | — | — | 4.48 | 4.16 |
ROA, derived = NI ÷ year-end total assets (%) | — | — | — | 2.82 | 2.43 |
Current ratio, derived (x) | — | — | — | 1.71 | 1.33 |
Liabilities / assets (%) | — | — | — | 52 | 57 |
Gross debt / parent equity, derived (x) | — | — | — | 0.42 | 0.45 |
Net debt / EBITDA, derived (x) | 2.45 | 2.92 | 4.05 | 0.73 | 0.97 |
Asset turnover, derived (x) | — | — | — | 0.22 | 0.18 |
Receivables turnover (x) | — | — | — | 8.36 | 7.40 |
Inventory turnover (x) | — | — | — | 0.39 | 0.33 |
Segment Overview
| Segment | Domestic exposure | Overseas exposure |
|---|---|---|
Dyes – Longsheng brands | High (Zhejiang, Jiangsu, Fujian, Guangdong dye houses) | Moderate (exports through traders and DyStar channels) |
Dyes and auxiliaries – DyStar | Moderate (Nanjing, Shanghai operations) | High (Asia ex-China, Turkey, Europe, Americas) |
Intermediates | High (Chinese dye makers, aramid, rubber chemicals) | Moderate (resorcinol and m-phenylenediamine exports to tyre and aramid makers in Asia, US and Europe) |
Real estate | 100% Shanghai | — |
Share Price & Returns
| Date | Close (CNY) | Source |
|---|---|---|
7 Jan 2026 | 11.51 | Google Finance |
21 Jul 2026 | 13.20 | Google Finance |
24 Jul 2026 | 12.28 (–7.25% on the day) | StockAnalysis |
26 Aug 2026 | 12.58 | Guosen |
2 Sep 2026 | About 12.2 (implied from Great Wall's 13.7x P/E on 2026E EPS of 0.89) | Great Wall |
24 Sep 2026 | 12.14 | Sohu margin data |
52-week high / low | 17.11 / 9.71 | Guosen |
Valuation Snapshot
| Metric | Value | Basis / source |
|---|---|---|
P/E (TTM) | About 20.4–21.8x | eniu / Google Finance (mid-2026) |
P/E 2026E | 13.7–15.3x | Great Wall / Guosen |
P/B | 1.24–1.30x; 41st percentile of 10-year range | Wind via Shenwan |
EV/EBITDA FY2025 | 29.6x (Guosen definition) | Guosen |
EV/Sales (TTM) | About 3.1x price-to-sales | China Securities Journal (Apr 2026) |
Dividend yield | About 4.2% (Google Finance, Jul 2026). Guosen expects 6.5% for 2026E on a 100% payout. | — |
Analyst Ratings & Targets
| Broker | Date | Rating | 2026E NP (CNY Mn) | 2027E NP (CNY Mn) | 2028E NP (CNY Mn) | Target / fair value |
|---|---|---|---|---|---|---|
Guosen Securities | 27 Aug 2026 | Outperform (initiation) | 2,685 | 2,919 | 3,008 | CNY 13.28–14.94 |
Shenwan Hongyuan | 27 Aug 2026 | Overweight (maintained) | 3,023 | 3,676 | 4,313 | — |
Great Wall Securities | 3 Sep 2026 | Accumulate (maintained) | 2,907 | 3,355 | 3,540 | — |
Dividend History
| Period | DPS (CNY) | Notes |
|---|---|---|
FY2022 final | 0.25 | FY2022 Annual Report |
FY2025 final | 0.10 | Paid June 2026 |
Q1 2026 | 0.35 | Ex-date 3 Jul 2026 |
Payout ratio (cash paid ÷ NI) FY2023 / FY2024 / FY2025 | 101.9% / 109.4% / 103.3% | Guosen |
Analyst Conclusions
Guidance and consensus
Management gives no numerical guidance. Its qualitative outlook (2026 interim report) points to:
-
continued benefit from intermediate self-sufficiency while dye prices rise;
-
orderly property delivery (Wanshang handover around end-2026);
-
stable rental income.
Sell-side estimates for 2026 net profit range from CNY 2.69 billion to 3.02 billion, which is +47% to +65% YoY. The 2026 revenue range is CNY 16.8–18.4 billion (+26% to +38%), helped by property handover recognition.
Bull case
-
Pricing power from integration. Reduction product (+380% YTD) and H-acid (+100%) shortages are structural, given approval barriers. Longsheng is one of only three stable reduction-product makers and is self-sufficient, so it captures both the intermediate and the dye spread. H1 2026 intermediate gross margin was 39.6%, up 10.3pp.
-
Earnings and cash catalysts converge. Recurring Q2 2026 profit rose 50% YoY. The Wanshang handover should release part of CNY 12.8 billion in contract liabilities, and DyStar profits are now 100% attributable.
-
Valuation and yield support. P/B of about 1.25–1.3x (41st percentile of 10 years), 2026E P/E of 14–15x and a 100%+ payout policy imply a yield of 6%+.
Bear case
-
Demand-less price rally. Dye-house orders remain weak. Disperse dye prices fell 32% between March and June 2026 before recovering, so supply-driven spikes may reverse when intermediate supply resumes.
-
Structurally low returns. ROE of about 6% despite 30%+ chemical margins because about CNY 40 billion is tied up in property. Payouts above earnings plus a CNY 13 billion debt programme suggest the dividend is partly debt-funded.
-
FX and earnings-quality noise. An FX loss of about CNY 216M in one quarter, and one-off gains of about CNY 500M in each of FY2024 and FY2025, make headline profit unreliable. Headline H1 2026 net profit grew only 8%.
Catalysts and monitorables (next 12 months)
-
Q3 2026 results (late October 2026): whether the 50% recurring-profit growth continues.
-
Disperse and reactive dye spot prices; reduction-product and H-acid prices; restart of competitors' H-acid units (Runtu, Wuhai Yadong).
-
Wanshang handover timing and recognised margin (Q4 2026 / Q1 2027).
-
2026 interim and quarterly dividend declarations and any buyback.
-
Drawdowns under the CNY 13 billion DFI programme and net-debt trend.
-
DyStar integration benefits and overseas demand (South and Southeast Asia).
-
Any safety or environmental incidents at Longsheng or peers.
Analyst verdict
Zhejiang Longsheng enters late 2026 at a cyclical inflection supported by its structure. The 2023–25 period combined falling dye prices, collapsing property revenue and an expensive fight over DyStar control. All three pressures have now eased or reversed. Dye prices rose 40–47% in the first half of 2026, with the increase driven by intermediate scarcity rather than end-demand. That distinction matters for Longsheng. Its self-supply of reduction product, m-phenylenediamine and H-acid means it captures the rally rather than suffering from it. This shows in intermediates outearning dyes, at 39.6% versus 36.7% gross margin, for the first time in the series. Full DyStar ownership, completed in January 2026 at about USD 702M, removes a minority claim and a decade of litigation. It also brings DyStar's retained earnings within reach of the listed parent's dividend policy.
The investment case still has limits. Longsheng is not a high-quality compounder. Its ROE of about 6% reflects a balance sheet in which property inventory and investment property outweigh the chemicals business. Headline earnings are regularly distorted by FX and one-off gains. The payout policy, above 100% for three years and now quarterly, is generous but increasingly debt-funded. The demand side is fragile: the textile cycle has not turned, and the March–June 2026 price round-trip showed how quickly sentiment can reverse.
On balance, the risk/reward is moderately favourable. At about CNY 12 per share, the stock trades on 14–15x consensus 2026E earnings and about 1.25x book. That price appears to assume the intermediate windfall fades. The yield above 6% pays investors to wait for the Wanshang handover and Q3–Q4 confirmation. The view is constructive, best held as a cyclical-plus-yield position rather than a structural growth holding. The key monitorables are intermediate prices, the property handover margin and leverage.
All figures are in CNY unless stated.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Title | Notes |
|---|---|---|
Ruan Weixiang (阮伟祥) | Chairman of the Board and General Manager | Son of founder Ruan Shuilong. Largest individual shareholder (13.09%). Led the 2024 share purchases and the DyStar buy-out. |
Lu Bangyi (卢邦义) | Director and Chief Financial Officer | Named participant in the FY2025 results briefing (17 Apr 2026) |
Yao Jianfang (姚建芳) | Director, Deputy General Manager and Board Secretary | Board secretary since at least FY2022 (FY2022 Annual Report) |
Zhao Gang (赵刚) | Independent Director | FY2025 results briefing participant |
Ruan Shuilong (阮水龙) | Founder. Second-largest shareholder (11.98%). | — |
Chen Guojiang (陈国江) | Securities Affairs Representative | FY2022 Annual Report |
Xu Yalin | President, DyStar Group | Quoted on the DyStar ownership transition, June 2025 |
Major Shareholders
| Rank | Holder | Shares (M) | Stake (%) | Change |
|---|---|---|---|---|
| 1 | Ruan Weixiang (阮伟祥) | 425.73 | 13.09 | Unchanged |
| 2 | Ruan Shuilong (阮水龙) | 389.65 | 11.98 | Unchanged |
| 3 | Hong Kong Securities Clearing (Northbound) | 127.65 | 3.92 | –30.04M |
| 4 | Longsheng 2023 Employee Share Ownership Plan | 97.60 | 3.00 | New entry |
| 5 | National Social Security Fund Portfolio 113 | 82.11 | 2.52 | +21.96M |
| 6 | Basic Pension Insurance Fund Portfolio 802 | 78.50 | 2.41 | +33.32M |
| 7 | Wang Long (王龙) | 44.66 | 1.37 | +1.30M |
| 8 | Pan Xiaocheng (潘小成) | 43.24 | 1.33 | +0.38M |
Competitive Landscape
Competitors by Segment
| Segment | Competitor | Country | Notes |
|---|---|---|---|
Dyes (disperse/reactive) | Zhejiang Runtu Co., Ltd. (闰土股份, 002440.SZ) | China | About 238 kt/y of dye capacity (118 kt disperse, 100 kt reactive), 8 kt reduction product, 90 kt chlorobenzenes. China #2 dye maker (company data via Guosen). |
Dyes | Zhejiang Jihua Group (吉华集团, 603980.SH) | China | Disperse dyes and H-acid. Hit by environmental shutdowns in 2018. |
Dyes | Shanghai Anoky Group (安诺其, 300067.SZ) | China | Disperse and reactive dyes, digital inks |
Dyes / intermediates | Hubei Chuyuan Group (楚源) | China (private) | Large H-acid and reactive dye producer |
Intermediates (reduction product) | Ningxia Zhongsheng (宁夏中盛) | China | 20 kt/y of reduction product, equal-largest supplier |
Pigments / dyes | Anshan Hifichem (七彩化学, 300758.SZ) | China | High-performance pigments and solvent dyes; 13.5 kt/y |
Global textile chemicals | Archroma (owner of ex-Huntsman Textile Effects since 2023) | Switzerland (SK Capital) | DyStar's closest global rival in branded dyes and auxiliaries |
Dyes | Atul Ltd | India | Diversified; colours segment |
Dyes / intermediates | Kiri Industries | India | Former DyStar partner; reactive dyes and H-acid |
Dyes | Colourtex Industries | India | Disperse and reactive dyes |
Dyes | Everlight Chemical (永光化學) | Taiwan | Reactive and disperse dyes |
Auxiliaries | CHT Group, Rudolf Group, Pulcra | Germany | Textile auxiliaries specialists |
Resorcinol | Sumitomo Chemical; INDSPEC (Hongye); domestic Chinese producers | Japan / USA / China | Global resorcinol oligopoly |
Peer Comparison FY2025
| Metric | Zhejiang Longsheng | Zhejiang Runtu | Anshan Hifichem |
|---|---|---|---|
Listing | 600352.SH | 002440.SZ | 300758.SZ |
FY2025 revenue (CNY Mn) | 13,313 | — | — |
FY2025 EPS (CNY) | 0.56 | 0.60 | 0.15 |
2026E EPS (CNY, Guosen) | 0.83 | 0.94 | 0.23 |
2026E P/E (x) | 15.3 | 13.9 | 49.8 |
P/B (x) | 1.30 | 1.48 | 2.55 |
Market cap (CNY 100M) | 417 | 147 | 46 |
Dye capacity (kt/y) | 330 (430 approved) | 238 | 13.5 (dyes and pigments) |
FY2025 R&D intensity (%) | 4.37 | — | — |



